Softwr

Healthcare · head to head

Fujifilm Synapse vs Lunit

Fujifilm Synapse logo

Fujifilm Synapse

Healthcare

Enterprise imaging platform covering PACS, VNA, cardiology and 3D from Fujifilm Healthcare

From
On request
Rated
-
Full reviewWebsite
Lunit logo

Lunit

Healthcare

FDA cleared and CE marked AI for mammography, tomosynthesis and chest radiography

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Fujifilm Synapse pACS, VNA, Cardiovascular and 3D are separately licensed and separately versioned, so an enterprise deployment means four upgrade cycles and four support relationships under one brand rather than one platform upgrade.; Lunit the regulatory permission differs by product and by region, and INSIGHT Risk has been filed with the FDA but not cleared, so a buyer who reads a corporate press release rather than the specific clearance for their product and jurisdiction will plan a deployment they cannot legally run.
  • They diverge on capability: Fujifilm Synapse covers Synapse PACS, Lunit covers Lunit INSIGHT MMG.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Fujifilm Synapse and Lunit actually diverge.

Attributes where Fujifilm Synapse and Lunit differ
AttributeFujifilm SynapseLunit
PlatformsWeb, Windows, iOS, AndroidWeb

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Fujifilm Synapse

  • Synapse PACS
  • Synapse VNA
  • Synapse Cardiovascular
  • Synapse 3D
  • Synapse Mobility
  • Deconstructed PACS support
  • Cloud services

Only in Lunit

  • Lunit INSIGHT MMG
  • Lunit INSIGHT DBT
  • Lunit INSIGHT CXR
  • Volpara density assessment
  • Volpara RiskPathways
  • Volpara dose tracking
  • PACS and mammography workstation integration

What people use each for

The jobs each tool is most often brought in to do.

Fujifilm Synapse

  • A hospital replacing PACS that wants the archive decoupled from its scanner vendor so future modality purchases stay competitivenot Lunit
  • A health system consolidating radiology, cardiology, ophthalmology and wound images into one vendor neutral archive with a single retention policynot Lunit
  • An outpatient imaging chain that needs one worklist across multiple sites and radiologists reading remotelynot Lunit
  • A site pursuing a deconstructed PACS strategy that wants to replace the viewer later without touching the archivenot Lunit

Lunit

  • A national breast screening programme evaluating AI as a second reader to reduce double reading workload where two human readers are currently mandatednot Fujifilm Synapse
  • A breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on DBT specificallynot Fujifilm Synapse
  • An American breast imaging centre needing automated volumetric density assessment to meet patient density notification requirements, which is what Volpara is bought fornot Fujifilm Synapse
  • A tuberculosis or lung screening programme in a high volume, radiologist scarce setting using chest radiography triage to prioritise filmsnot Fujifilm Synapse

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Fujifilm Synapse

  • PACS, VNA, Cardiovascular and 3D are separately licensed and separately versioned, so an enterprise deployment means four upgrade cycles and four support relationships under one brand rather than one platform upgrade.
  • Synapse 3D is licensed by concurrent user and sized from average concurrency, which leaves radiologists queued for advanced visualisation at the morning reading peak and forces an unplanned licence purchase.
  • As an independent informatics vendor Fujifilm has less privileged access to proprietary modality data than Philips or Siemens have on their own scanners, so some vendor specific post processing is not available.
  • The vendor neutral archive absorbs non DICOM object types only after per specialty configuration work, and departments such as ophthalmology and dermatology usually need bespoke ingestion projects that were not in the original scope.
  • Migrating a decade of priors from a legacy archive is a large professional services line that Fujifilm quotes separately, and these migrations regularly run past the contracted go live date.

Lunit

  • The regulatory permission differs by product and by region, and INSIGHT Risk has been filed with the FDA but not cleared, so a buyer who reads a corporate press release rather than the specific clearance for their product and jurisdiction will plan a deployment they cannot legally run.
  • Detection AI changes recall rates in screening, and the downstream cost of additional diagnostic workup lands on the programme rather than on the software budget, which is the cost most screening business cases omit.
  • Performance is sensitive to the mammography vendor and acquisition protocol, so published results from a Hologic estate do not transfer to a GE or Siemens estate without local validation the buyer must fund.
  • MMG, DBT and CXR are licensed separately and Volpara modules are separate again, so a breast centre wanting detection, density and risk pathways is assembling four line items rather than buying one product.
  • Using AI as a replacement for one of two human readers is a workforce and liability decision that regulators and professional bodies treat differently in each country, so the saving that justifies the purchase may not be permitted where you operate.

Pricing, plan by plan

Fujifilm Synapse

On request
  • Synapse$undefined/year
    • Each module licensed separately: PACS, VNA, Cardiovascular, 3D
    • Priced by annual study volume and concurrent diagnostic users
    • Synapse 3D licensed by concurrent user, separate from PACS

Lunit

On request
  • Lunit INSIGHT$undefined/year
    • Priced per study or per annual examination volume by product
    • MMG, DBT and CXR licensed separately
    • Volpara density and RiskPathways modules quoted separately

Which should you pick?

Choose Fujifilm Synapse if

  • You need synapse pacs.
  • You work on Web, Windows, iOS, Android.
  • You also want synapse vna.
Fujifilm Synapse review

Choose Lunit if

  • You need lunit insight mmg.
  • You also want lunit insight dbt.
Lunit review

Questions people ask

Is Fujifilm Synapse or Lunit better?
Neither clearly leads. Fujifilm Synapse starts at On request and Lunit at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Fujifilm Synapse or Lunit?
Fujifilm Synapse starts at On request and Lunit at On request.
Does Fujifilm Synapse or Lunit run on more platforms?
Fujifilm Synapse runs on Web, Windows, iOS, Android. Lunit runs on Web.
What is Fujifilm Synapse best used for?
Fujifilm Synapse is most often used for a hospital replacing pacs that wants the archive decoupled from its scanner vendor so future modality purchases stay competitive, a health system consolidating radiology, cardiology, ophthalmology and wound images into one vendor neutral archive with a single retention policy, an outpatient imaging chain that needs one worklist across multiple sites and radiologists reading remotely, a site pursuing a deconstructed pacs strategy that wants to replace the viewer later without touching the archive. Of those, a hospital replacing pacs that wants the archive decoupled from its scanner vendor so future modality purchases stay competitive and a health system consolidating radiology, cardiology, ophthalmology and wound images into one vendor neutral archive with a single retention policy are not what Lunit is typically brought in for.
What can Fujifilm Synapse do that Lunit cannot?
Fujifilm Synapse covers Synapse PACS, Synapse VNA, Synapse Cardiovascular, Synapse 3D. Lunit covers Lunit INSIGHT MMG, Lunit INSIGHT DBT, Lunit INSIGHT CXR, Volpara density assessment.

Answered from the vendors’ own pages

Fujifilm Synapse: Is Synapse one product or several?

Several. Synapse PACS, Synapse VNA, Synapse Cardiovascular and Synapse 3D are separately licensed products under one brand. Price and scope each one individually.

Lunit: Is Lunit FDA cleared?

Yes for specific products. INSIGHT MMG, INSIGHT DBT and INSIGHT CXR Triage hold FDA 510(k) clearances. INSIGHT Risk, the five year risk prediction model, has been filed but was not cleared at the time of writing.

Fujifilm Synapse: Do I have to buy Fujifilm scanners?

No. Fujifilm sells Synapse independently of imaging hardware, which is a large part of why it wins competitive PACS replacements at mixed fleet sites.

Lunit: Can Lunit replace a second human reader in screening?

That depends entirely on your jurisdiction and professional body guidance, not on the software. The CE mark permits clinical use; it does not authorise a workforce model.

Fujifilm Synapse: Does Synapse publish pricing?

No. Pricing is quoted by study volume, concurrent users, module mix and storage capacity.

Lunit: What did the Volpara acquisition add?

Volumetric breast density measurement, dose tracking and RiskPathways high risk programme management, which are the things American breast centres buy for density notification compliance rather than for detection.

Fujifilm Synapse: Can Synapse VNA store non radiology images?

Yes, including visible light, ophthalmology and wound photography, but each specialty typically needs its own ingestion and metadata configuration project.

Lunit: Is pricing published?

No. It is quoted per study or per annual volume, by product, with on premises and cloud priced differently.

Share

Related pages

More on Fujifilm Synapse

More on Lunit

Keep looking

Other head to heads